Skip to main content
. 2020 Apr 17;12(4):997. doi: 10.3390/cancers12040997

Figure 2.

Figure 2

ERBB4 deletion impairs migration during cerebellum development and its activation protects CGNPs from apoptosis. (A) Representative immunofluorescence images of the indicated proteins in p20 wt and ErbB4 KO mouse cerebellum. (B) Western blot analysis of indicated proteins in CGNPs from wt p5 mice treated with the indicated compounds (n ≥ 3). (C) Western blot analysis of the indicated proteins in CGNPs from wt and ErbB4 KO p5 mice treated with the indicated compounds (n ≥ 3). (D) Western blot analysis of the indicated proteins obtained from p15 cerebellum from SmoM2; ErbB4 Het or KO mice. The uncropped blots and molecular weight markers are shown in Figures S8–S10.